BCAL Diagnostics lists on ASX after raising $10 million in IPO

SYDNEY, AUSTRALIA: BCAL Diagnostics listed on the Australian Securities Exchange (ASX) following an Initial Public Offering (IPO) that raised $10 million from investors. The offer saw the issue of 40 million new shares at 25 cents per share, valuing BCAL at $51.7 million. BCAL is developing a non-invasive laboratory blood test for the detection of…

Aussie Broadband lists on the ASX following a capital raise of $40m

PERTH: Aussie Broadband Limited (ABB) has been admitted to the official list of the Australian Securities Exchange (ASX) following the successful completion of a $40.00 million initial public offering (IPO). Under the IPO, 40 million shares were issued at $1 a share, which gives Aussie Broadband Limited (ABB) a market capitalisation of approximately $190 million…